Clinical Trial Update: ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of Narazaciclib in combination with dexamethasone for relapsed and/or refractory multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Narazaciclib (Narazaciclib)

Snippet

Sponsor: Adriana Rossi | Conditions: Relapsed and/or Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED